AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2024
Feb 26, 2024
34301_dirs_2024-02-26_13c5cf1d-a9af-4935-bb61-4b37fdd77897.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-02-22
Reporting Person: Sims Andrew John Hugh MacIntyre (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | Stock Option (Right to Buy) | $2.03 | A | 18933 | Acquired | 2034-02-22 | Common Stock (18933) | Direct |
Footnotes
F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27